NMRA-335140 80 mg

Drug identity checked against registry records

Also recorded as BTRX-335140; CYM-53093; Navacaprant

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.NCT06429722NMRAPhase 2Completed2025-04-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.